Nid ydym yn gwybod a yw'r ymateb mwyaf diweddar i'r cais hwn yn cynnwys gwybodaeth neuai peidio - os chi ywTracy Mallinson mewngofnodwch a gadael i bawb wybod.

Levothyroxine Formulated Products

Tracy Mallinson made this Rhyddid Gwybodaeth request to Commission on Human Medicines

This request has been closed to new correspondence from the public body. Contact us if you think it ought be re-opened.

We're waiting for Tracy Mallinson to read a recent response and update the status.

Dear Commission on Human Medicines,

I understand The Commission on Human Medicines has recently reviewed the regulation of Levothyroxine formulated products.

Please send me via e-mail:

Copies of the minutes of any meetings, any reports, papers or internal correspondence relating to your review of Levothyroxine Formulated Products.

Thank you for your help with this matter.

Yours faithfully,

Tracy Mallinson

Whitbread, Leslie, Commission on Human Medicines

As from 2 July 2012 all emails relating to centralsiesd procedures and MR/DC procedures should be directed to Mr Robin Fraser who now heads the Unit at [email address].

Swati Singh is looking after all matters relating to Committees (CHM, EAGs, HMAC (herbals), ABRHP (homeopathics) and the Panels (Advertising and Borderline)

I will only be concerned with business relating to national advisory bodies as an adviser to the Unit.

dangos adrannau a ddyfynnir

Dear Whitbread, Leslie,

It's not my problem that your job role has changed.

I didn't choose to send this to you but it is an automated process and you are obviously the one that is named as the main FOI contact address for your organisation.

This automated system does not provide the functionality for me to direct it to anyone else. As you are the registered person please ensure my request is handled according to The FOI Act 2000.

Yours sincerely,

Tracy Mallinson

Dear Commission on Human Medicines,

I still haven't received an acknowledgement for my FOI request other than a rambling note form someone telling me their job has changed. I am expecting a response to my questions within the designated timeframe. Please wil you send formal acknowledgement that you are working on this.

Yours faithfully,

Tracy Mallinson

Whitbread, Leslie, Commission on Human Medicines

As from 2 July 2012 all emails relating to centralsiesd procedures and MR/DC procedures should be directed to Mr Robin Fraser who now heads the Unit at [email address].

Swati Singh is looking after all matters relating to Committees (CHM, EAGs, HMAC (herbals), ABRHP (homeopathics) and the Panels (Advertising and Borderline)

I will only be concerned with business relating to national advisory bodies as an adviser to the Unit. I will now be on leave form 3/9 returning on 19/9.

dangos adrannau a ddyfynnir

Dear Whitbread, Leslie,

I'm a bit sick of you saying you are not dealing with this any more. It is no good you sending me other contact details in the organisation. You should have forwarded this on to the right person. Now you have missed the deadline. This is an automated service and I can't update the details for you. YOU need to register a change of main contact. Also it's about time you learnt how to spell centralised.

Yours sincerely,

Tracy Mallinson

MHRA Customer Services, Commission on Human Medicines

Dear Tracy Mallinson,

Thank you for your enquiry to the MHRA.

Your original request to us regarding this issue was as follows:

"Dear Commission on Human Medicines,

I understand The Commission on Human Medicines has recently
reviewed the regulation of Levothyroxine formulated products.

Please send me via e-mail:

Copies of the minutes of any meetings, any reports, papers or
internal correspondence relating to your review of Levothyroxine
Formulated Products.

Thank you for your help with this matter.

Yours faithfully,

Tracy Mallinson"

This was received and acknowledged with the reference number FOI 12/331. However, we sent this to another whatdotheyknow email address ( [email address] ) which I believe you used to make a different request (FOI 12/332). Please accept our apologies for this and any inconvenience subsequently caused.

We will be sending a response to your request shortly, and are grateful to you for your patience.

Finally, we will be in touch with the whatdotheyknow team to amend the details which they hold for the Commission on Human Medicines.

Ben,
Customer Services
External Relations
Medicines and Healthcare products Regulatory Agency
Tel: 020 3080 6000

dangos adrannau a ddyfynnir

Dear MHRA Customer Services,

I am still awaiting a response to my FOI request.

Yours sincerely,

Tracy Mallinson

MHRA Customer Services, Commission on Human Medicines

Dear Enquirer,
 
Thank you for your enquiry to the MHRA. This automated response confirms
that we have received your email and that it will be dealt with as quickly
as possible.
 
You can expect a reply from us within a few days for a straightforward
request, however where a more detailed response or contribution from a
specialist is required this is likely to take longer; we endeavour to
respond to all requests within the Department of Health’s target response
time of 20 working days. Further information on how we handle different
requests can be found on our website at the link below:
 
[1]http://www.mhra.gov.uk/Contactus/Central...
 
The MHRA website contains a wealth of information which may assist with
your enquiry. Some of our popular pages are:
 
Clinical Trials of medicines:
 
[2]http://www.mhra.gov.uk/Howweregulate/Med...
       
Clinical Trials of medical devices:
 
[3]http://www.mhra.gov.uk/Howweregulate/Dev...
 
Manufacturer’s and wholesale dealer’s licences:

[4]http://www.mhra.gov.uk/Howweregulate/Med...
 
Registration of medical devices, opticians and dental laboratories:

[5]http://www.mhra.gov.uk/Howweregulate/Dev...
 
Reporting a side effect to a medicine:

[6]http://www.mhra.gov.uk/Safetyinformation...
 
Reporting an adverse incident involving a medical device:
 
[7]http://www.mhra.gov.uk/Safetyinformation...
 
Does my product need a licence?:

[8]http://www.mhra.gov.uk/Howweregulate/Med...
 
Reporting a counterfeit medical product:
 
[9]http://www.mhra.gov.uk/Safetyinformation...
 
Buying medicines over the internet:
 
[10]http://www.mhra.gov.uk/Safetyinformation...
 
 
If you have not heard from us after 20 working days then please contact us
on 020 3080 6000.
 
Kind regards
 
Customer Services
External Relations
Medicines and Healthcare products Regulatory Agency
 
Please note this is an automated reply; please do not respond to this
message.
 
 
 

This email and any files transmitted with it are confidential. If you are
not the intended recipient, any reading, printing, storage, disclosure,
copying or any other action taken in respect of this email is prohibited
and may be unlawful.

 

If you are not the intended recipient, please notify the sender
immediately by using the reply function and then permanently delete what
you have received.Incoming and outgoing email messages are routinely
monitored for compliance with the Department of Healths policy on the use
of electronic communications.

 

For more information on the Department of Healths email policy, click

http://www.dh.gov.uk/DHTermsAndCondition...

dangos adrannau a ddyfynnir

Communications via the GSi may be automatically logged, monitored and/or
recorded for legal purposes.

References

Visible links
1. http://www.mhra.gov.uk/Contactus/Central...
2. http://www.mhra.gov.uk/Howweregulate/Med...
3. http://www.mhra.gov.uk/Howweregulate/Dev...
4. http://www.mhra.gov.uk/Howweregulate/Med...
5. http://www.mhra.gov.uk/Howweregulate/Dev...
6. http://www.mhra.gov.uk/Safetyinformation...
7. http://www.mhra.gov.uk/Safetyinformation...
8. http://www.mhra.gov.uk/Howweregulate/Med...
9. http://www.mhra.gov.uk/Safetyinformation...
10. http://www.mhra.gov.uk/Safetyinformation...

Dear MHRA Customer Services,

This does not answer my FOI request - I already used the links you give before I raised my request. It is as a result of information about the withdrawal of levothyroxine products on the MHRA website that I know about this problem and why I asked for the information.

I believe this is just a delaying tactic and the recent withdrawal of yet another product i.e. Evotrox is confirming my concerns about the effacy of these products.

You are already well past the date to meet the requirements of the law.

Yours sincerely,

Tracy Mallinson

MHRA Customer Services, Commission on Human Medicines

Dear Enquirer,
 
Thank you for your enquiry to the MHRA. This automated response confirms
that we have received your email and that it will be dealt with as quickly
as possible.
 
You can expect a reply from us within a few days for a straightforward
request, however where a more detailed response or contribution from a
specialist is required this is likely to take longer; we endeavour to
respond to all requests within the Department of Health’s target response
time of 20 working days. Further information on how we handle different
requests can be found on our website at the link below:
 
[1]http://www.mhra.gov.uk/Contactus/Central...
 
The MHRA website contains a wealth of information which may assist with
your enquiry. Some of our popular pages are:
 
Clinical Trials of medicines:
 
[2]http://www.mhra.gov.uk/Howweregulate/Med...
       
Clinical Trials of medical devices:
 
[3]http://www.mhra.gov.uk/Howweregulate/Dev...
 
Manufacturer’s and wholesale dealer’s licences:

[4]http://www.mhra.gov.uk/Howweregulate/Med...
 
Registration of medical devices, opticians and dental laboratories:

[5]http://www.mhra.gov.uk/Howweregulate/Dev...
 
Reporting a side effect to a medicine:

[6]http://www.mhra.gov.uk/Safetyinformation...
 
Reporting an adverse incident involving a medical device:
 
[7]http://www.mhra.gov.uk/Safetyinformation...
 
Does my product need a licence?:

[8]http://www.mhra.gov.uk/Howweregulate/Med...
 
Reporting a counterfeit medical product:
 
[9]http://www.mhra.gov.uk/Safetyinformation...
 
Buying medicines over the internet:
 
[10]http://www.mhra.gov.uk/Safetyinformation...
 
 
If you have not heard from us after 20 working days then please contact us
on 020 3080 6000.
 
Kind regards
 
Customer Services
External Relations
Medicines and Healthcare products Regulatory Agency
 
Please note this is an automated reply; please do not respond to this
message.
 
 
 

This email and any files transmitted with it are confidential. If you are
not the intended recipient, any reading, printing, storage, disclosure,
copying or any other action taken in respect of this email is prohibited
and may be unlawful.

 

If you are not the intended recipient, please notify the sender
immediately by using the reply function and then permanently delete what
you have received.Incoming and outgoing email messages are routinely
monitored for compliance with the Department of Healths policy on the use
of electronic communications.

 

For more information on the Department of Healths email policy, click

http://www.dh.gov.uk/DHTermsAndCondition...

dangos adrannau a ddyfynnir

Communications via the GSi may be automatically logged, monitored and/or
recorded for legal purposes.

References

Visible links
1. http://www.mhra.gov.uk/Contactus/Central...
2. http://www.mhra.gov.uk/Howweregulate/Med...
3. http://www.mhra.gov.uk/Howweregulate/Dev...
4. http://www.mhra.gov.uk/Howweregulate/Med...
5. http://www.mhra.gov.uk/Howweregulate/Dev...
6. http://www.mhra.gov.uk/Safetyinformation...
7. http://www.mhra.gov.uk/Safetyinformation...
8. http://www.mhra.gov.uk/Howweregulate/Med...
9. http://www.mhra.gov.uk/Safetyinformation...
10. http://www.mhra.gov.uk/Safetyinformation...

MHRA Customer Services, Commission on Human Medicines

1 Atodiad

Dear Ms Mallinson,
 
Please find attached our response to your request, which was sent out on
the 21st September.
 
Kind Regards
 
Customer Services
External Relations
MHRA
T: 020 3080 6000 

dangos adrannau a ddyfynnir

Gadawodd Tracy Mallinson anodiad ()

I received reasonably acceptable answers to my questions on my other freedom of information request to the MHRA (No 332)

MHRA Customer Services, Commission on Human Medicines

 
 
Dear Tracy Mallinson,
 
We are contacting you following correspondence we had with you in 2012
regarding levothyroxine; it is as a result of this correspondence that you
may be interested in a report which we have recently published.
 
The MHRA conducted a review of levothyroxine products licensed in the UK
following concerns expressed by patients and healthcare professions over
potential inconsistencies in the quality and effectiveness of
levothyroxine products. Recommendations from this review were endorsed in
March 2012 by the Commission on Human Medicines, an independent panel of
experts who advise the licensing authority.
A report of this review is available on our website at the link below and
contains recommendations aimed at strengthening quality controls and
regulatory requirements for all levothyroxine products. You can access the
report by following the link below:

[1]http://www.mhra.gov.uk/Safetyinformation...
 
Please get in touch with us should you have any questions about this
report.
 
Kind Regards,
 
Ben,
Customer Services
External Relations
Medicines and Healthcare products Regulatory Agency
Tel: 020 3080 6000
 
Your views matter. Tell us what you think of the service you have received
from us by following the link below:
[2]https://www.surveymonkey.com/s/MHRACusto...
 
 
 

This email and any files transmitted with it are confidential. If you are
not the intended recipient, any reading, printing, storage, disclosure,
copying or any other action taken in respect of this email is prohibited
and may be unlawful.

 

If you are not the intended recipient, please notify the sender
immediately by using the reply function and then permanently delete what
you have received.Incoming and outgoing email messages are routinely
monitored for compliance with the Department of Healths policy on the use
of electronic communications.

 

For more information on the Department of Healths email policy, click

http://www.dh.gov.uk/DHTermsAndCondition...

dangos adrannau a ddyfynnir

Communications via the GSi may be automatically logged, monitored and/or
recorded for legal purposes.

References

Visible links
1. http://www.mhra.gov.uk/Safetyinformation...
2. https://www.surveymonkey.com/s/MHRACusto...

Nid ydym yn gwybod a yw'r ymateb mwyaf diweddar i'r cais hwn yn cynnwys gwybodaeth neuai peidio - os chi ywTracy Mallinson mewngofnodwch a gadael i bawb wybod.